GTS Securities’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-24,715
Closed -$593K 1552
2025
Q2
$593K Buy
24,715
+987
+4% +$23.4K 0.03% 582
2025
Q1
$564K Buy
+23,728
New +$561K 0.02% 627
2024
Q4
Sell
-19,630
Closed -$473K 2543
2024
Q3
$473K Buy
19,630
+1,910
+11% +$45.6K ﹤0.01% 2876
2024
Q2
$413K Buy
17,720
+6,096
+52% +$142K ﹤0.01% 2855
2024
Q1
$273K Buy
+11,624
New +$273K ﹤0.01% 3078

Other funds holding IBD

GTS Securities's IBD Position: Q3 2025 in Review

GTS Securities sold out of Inspire Corporate Bond ETF (IBD) in Q3 2025, closing a stake of 24,715 shares — an estimated $593K sold.

GTS Securities first reported a position in IBD in Q1 2024 and held it in 5 quarters. The position peaked at $593K in Q2 2025. 97 funds tracked by Wall St. Rank hold IBD as of Q3 2025.

  • GTS Securities reported no remaining Inspire Corporate Bond ETF position as of Q3 2025 after selling out during the quarter.
  • GTS Securities sold 24,715 Inspire Corporate Bond ETF shares in Q3 2025, an estimated $593K.
  • GTS Securities first reported a position in Inspire Corporate Bond ETF in Q1 2024 and held it in 5 quarters.
  • GTS Securities's Inspire Corporate Bond ETF position peaked at $593K in Q2 2025.
  • 97 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q3 2025.

Based on GTS Securities's 13F filing for Q3 2025, filed 14 Nov 2025.